Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy
Combination chemotherapy is widely exploited for suppressing drug resistance and
achieving synergistic anticancer efficacy in the clinic. In this paper, the nanostructured …
achieving synergistic anticancer efficacy in the clinic. In this paper, the nanostructured …
Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery
L Xu, XY He, BY Liu, C Xu, SL Ai, RX Zhuo… - Colloids and Surfaces B …, 2018 - Elsevier
Proteins have been extensively explored as versatile nanocarriers for drug delivery due to
their complete biocompatibility, ease of surface modification, and lack of toxicity and …
their complete biocompatibility, ease of surface modification, and lack of toxicity and …
Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer
Paclitaxel has been extensively used in clinics for cancer treatment. However, its limited
solubility in aqueous solution and high occurrence of side effects have also been widely …
solubility in aqueous solution and high occurrence of side effects have also been widely …
[HTML][HTML] Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer
The present study was carried out to develop cisplatin-loaded chitosan nanoparticles
(CCNP) and cisplatin-loaded chitosan nanoparticle surface linked to rituximab (mAbCCNP) …
(CCNP) and cisplatin-loaded chitosan nanoparticle surface linked to rituximab (mAbCCNP) …
[HTML][HTML] HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment …
T Duan, Z Xu, F Sun, Y Wang, J Zhang, C Luo… - Biomedicine & …, 2019 - Elsevier
Breast cancer is a fairly common cancer with high mortality in women worldwide. Targeted
nano-drug delivery system for breast cancer treatment has achieved encouraging results …
nano-drug delivery system for breast cancer treatment has achieved encouraging results …
Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines
J Dhanapal… - … cells, nanomedicine, and …, 2018 - Taylor & Francis
The aim of the study was to synthesize nanoparticles (NPs) with chitosan (CS), and poly
(lactic acid)(PLA) as a carrier for the drug piceatannol (PIC). The synthesized nanoparticles …
(lactic acid)(PLA) as a carrier for the drug piceatannol (PIC). The synthesized nanoparticles …
Folic-acid adorned alginate-polydopamine modified paclitaxel/Zn-CuO nanocomplex for pH triggered drug release and synergistic antitumor efficacy
Targeted chemotherapy is a prominent cancer treatment research trend that intends to boost
the efficacy of drug delivery to cancer cells. The present work aimed to design, a folate …
the efficacy of drug delivery to cancer cells. The present work aimed to design, a folate …
[HTML][HTML] Unveiling the potentials of biocompatible silver nanoparticles on human lung carcinoma A549 cells and Helicobacter pylori
Silver nanoparticles (AgNPs) are gaining importance in health and environment. This study
synthesized AgNPs using the bark extract of a plant, Toxicodendron vernicifluum (Tv) as …
synthesized AgNPs using the bark extract of a plant, Toxicodendron vernicifluum (Tv) as …
Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer
In present investigation, we developed paclitaxel (PTX)-loaded adenosine (ADN)-
conjugated PLGA nanoparticles for combating triple-negative breast cancer (TNBC), where …
conjugated PLGA nanoparticles for combating triple-negative breast cancer (TNBC), where …
[HTML][HTML] Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small …
T Tan, Y Feng, W Wang, R Wang, L Yin, Y Zeng… - Cancer …, 2023 - Springer
Background In the current treatment of non-small cell lung cancer (NSCLC), traditional
chemotherapy causes high toxicity, so it is necessary to develop safe chemical drug delivery …
chemotherapy causes high toxicity, so it is necessary to develop safe chemical drug delivery …